Growth Metrics

Inspire Medical Systems (INSP) Gains from Investment Securities (2017 - 2026)

Inspire Medical Systems' Gains from Investment Securities history spans 9 years, with the latest figure at $548000.0 for Q1 2026.

  • On a quarterly basis, Gains from Investment Securities rose 7.03% to $548000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $7.0 million, a 1272.27% increase, with the full-year FY2025 number at $4.0 million, changed N/A from a year prior.
  • Gains from Investment Securities hit $548000.0 in Q1 2026 for Inspire Medical Systems, down from $2.5 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for INSP hit a ceiling of $16.9 million in Q4 2023 and a floor of -$2.5 million in Q3 2023.
  • Historically, Gains from Investment Securities has averaged $2.2 million across 4 years, with a median of $548000.0 in 2026.
  • The widest YoY moves for Gains from Investment Securities: up 3960.47% in 2023, down 2669.79% in 2023.
  • Tracing INSP's Gains from Investment Securities over 4 years: stood at $96000.0 in 2022, then surged by 17512.5% to $16.9 million in 2023, then tumbled by 85.34% to $2.5 million in 2025, then plummeted by 77.89% to $548000.0 in 2026.
  • Business Quant data shows Gains from Investment Securities for INSP at $548000.0 in Q1 2026, $2.5 million in Q4 2025, and $4.0 million in Q2 2025.